Product is Japan’s first second-generation drug-eluting stent NATICK, Mass., Jan. 28 (HSMN NewsFeed) — Boston Scientific Corporation (NYSE: BSX ) announced today that it has received approval from the Japanese Ministry of Health, Labor and Welfare (M…
Devices, Interventional Cardiology, Regulatory
Boston Scientific, TAXUS Liberte, Paclitaxel, drug eluting stent

If you are a sales professional or want to become one, or if you are looking for a new sales job, you will face one of the toughest interview processes of any job seeker.
0 Comments on “Boston Scientific Announces Japanese Approval for TAXUS(R) Liberte(R) Drug-Eluting Stent System”
Leave a Comment